Isoboldine exhibits significant pharmacological potential, particularly in the area of central nervous system modulation. It acts as a dopamine receptor antagonist, which contributes to its sedative and tranquilizing effects. This property makes it a candidate of interest for managing anxiety and sleep disorders.

It also demonstrates anti-inflammatory and antioxidant activities, suggesting possible use in mitigating neurodegenerative conditions where oxidative stress and inflammation play key roles, such as Parkinson’s or Alzheimer’s disease.

Additionally, isoboldine has shown spasmolytic effects, meaning it can help relax smooth muscle contractions, which may be beneficial in treating gastrointestinal disorders like irritable bowel syndrome.

Research indicates potential antiproliferative effects on certain cancer cell lines, pointing to a role in oncology, though this area requires further investigation. Due to its natural origin and multi-target activity, isoboldine is considered a lead compound for developing new therapeutic agents in neuropharmacology and metabolic disease.